Latest Asx Listings News

First Graphene Limited has raised A$3.5 million through a share placement to accelerate the commercial adoption of its PureGRAPH graphene products and support ongoing operations.

Clime Investment Management’s CIWO securities have been suspended from trading due to regulatory non-compliance, raising questions about the company’s next steps and investor impact.

Lincoln Minerals Limited has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information is driving the activity.

Altair Minerals has raised A$13 million through an institutional placement led by 1832 Asset Management, fully funding an extensive drilling program at its Greater Oko Project set to begin early next year.

NRW Holdings showcased strong FY25 proforma results and ambitious FY26 guidance at the UBS Conference, underpinned by strategic acquisitions and a diversified portfolio. The company’s growth strategy focuses on expanding capabilities in energy transition and infrastructure markets across Australia, New Zealand, and North America.

MA Financial Group advances exclusive due diligence on a major Queensland retail asset and prepares a new ASX-listed credit notes offer, signaling strategic growth moves.

Ballard Mining Limited has released a comprehensive investor update following its July 2025 IPO, highlighting a robust 1.1 million ounce gold resource at Mt Ida and a strong cash position of $40 million. The company outlines ambitious exploration targets and development plans aiming to extend mine life beyond a decade.

Gladiator Resources has provided detailed clarifications to the ASX regarding its agreement with Apex USA Resources LLC for rare earth tenements in California, highlighting ongoing disputes and incomplete project milestones.

Eagle Mountain Mining has requested a voluntary suspension of its ASX-listed securities pending a capital raising announcement, with trading expected to resume by 11 November 2025.

Embark Early Education has announced an off-market takeover bid for Mayfield Childcare, valuing the company at nearly $38 million and offering shareholders a premium over recent prices. The move aims to create a larger childcare group with enhanced resources and educational outcomes.

Light & Wonder, Inc. is set to extend its substantial share repurchase program to include its ASX-listed CHESS Depositary Interests starting November 7, 2025, coinciding with its planned Nasdaq delisting.

Chimeric Therapeutics has responded to ASX inquiries regarding the disclosure timing and materiality of new clinical data from its ADVENT-AML trial, emphasizing compliance with continuous disclosure rules and the careful verification of promising patient responses.